skip to Main Content

Spinraza approved in China

  • 4 March 2019

An estimated 30 to 40 thousand people with spinal muscular atrophy will soon have access to the first-ever effective treatment for this life-limiting disorder as China’s health authorities granted marketing authorisation to nusinersen (Spinraza®).

Read More
Back To Top